The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LIGHTHOUSE (OP-108): A phase 3 study of melflufen in combination with dexamethasone (dex) and daratumumab (dara) versus dara in relapsed/refractory multiple myeloma (RRMM) patients (pts).
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Luděk Pour
No Relationships to Disclose
 
Enrique M. Ocio
Honoraria - Amgen; Asofarma; Bristol-Myers Squibb; Janssen; MSD; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Mundipharma; Oncopeptides; Sanofi; Secura Bio; Takeda
Speakers' Bureau - Janssen-Cilag; Takeda
Research Funding - Amgen (Inst); Array BioPharma (Inst); Celgene (Inst); IDP Pharmaceuticals (Inst); Mundipharma (Inst)
Travel, Accommodations, Expenses - Celgene; Janssen; Sanofi; Takeda
 
Pieter Sonneveld
Consulting or Advisory Role - Amgen; CARsgen Therapeutics; Celgene; Janssen; Karyopharm Therapeutics
Research Funding - Amgen (Inst); Janssen (Inst); Skyline Diagnostics (Inst)
 
Catarina Jansson Blixt
Employment - Oncopeptides
 
Kajsa Larsson
Employment - Alnylam; Oncopeptides
Stock and Other Ownership Interests - Alnylam
 
Linda Palmér
Employment - Oncopeptides
Stock and Other Ownership Interests - Oncopeptides
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Secura Bio; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)